BFM
DXCM icon

Boothbay Fund Management’s DexCom DXCM Stock Holding History

Boothbay Fund Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,600
Closed -$460K – 2354
2022
Q1 		$460K Buy
+3,600
New +$394K 0.01% 1344

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boothbay Fund Management's DXCM Position: Q2 2026 in Review

Boothbay Fund Management increased its DexCom (DXCM) stake by 98% in Q2 2026, buying an estimated $293K and bringing the position to 8,883 shares worth $598K. The position accounts for 0.01% of the portfolio, ranked #1384.

Boothbay Fund Management first reported a position in DXCM in Q4 2016 and has held it in 14 quarters since. The position peaked at $5.94M in Q3 2023. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Boothbay Fund Management held 8,883 shares of DexCom worth $598K as of Q2 2026.
  • Boothbay Fund Management bought 4,397 DexCom shares in Q2 2026, an estimated $293K.
  • DexCom made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1384 holding.
  • Boothbay Fund Management first reported a position in DexCom in Q4 2016 and has held it in 14 quarters since.
  • Boothbay Fund Management's DexCom position peaked at $5.94M in Q3 2023.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.